Canadian application, no grantCanada
Constructs and their use in metabolic pathway engineering
CA 2421059 A1 · Owner: Maxygen, Inc. · Inventors: Zhu, Genhai; Liu, Lu
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to methods and techniques for the expression of metabolic pathways, novel gene fusion constructs encoding multifunctional enzymatic domains, and related hybrid proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 16, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 16, 2001
GrantedNo grant recorded
Term endedAugust 16, 2021
Patent numberCA 2421059 A1
Classification (IPC)C12N15/82 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.